A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between several Medtronic Inc. (NYSE:MDT) subsidiaries and NuVasive Inc. (NSDQ:NUVA).
Accuray CEO: TomoTherapy integration starting to take shape
Accuray Inc.’s (NSDQ:ARAY) nearly $300 million deal to buy TomoTherapy Inc. (NSDQ:TOMO) isn’t closed yet, but the integration of the two companies is already underway.
Accuray CEO Euan Thomson wrote in an email to employees that the company isn’t officially beginning the process until the deal closes, but the Sunnyvale, Calif.-based CyberKnife radiosurgery device maker is already taking steps to ensure a smooth transition.
Accuray lines up $277 million TomoTherapy buyout | Acquisitions roundup
Accuray Inc. (NSDQ:ARAY) looks set to acquire radiation treatment firm TomoTherapy Inc. (NSDQ:TOMO) in a deal worth $277 million.
The Sunnyvale, Calif.-based radiosurgery company signed an agreement to buy TomoTherapy for $4.80 per share in cash and stock, a nearly 31 percent premium over its $3.67 closing price on Friday, March 4.
The companies believe their technologies complement one another in that they can serve overlapping patient populations.
